Advertisement

P1.10-005 Generation of Symptom Burden Patient-Reported Outcomes for Patients with Lung Cancer

      Systematic collection of patient experience of disease and treatment through validated patient-reported outcome measures (PROs) is recommended for research and practice. Symptom burden, the combined impact of disease- and therapy-related symptoms on daily functioning, is important to patients and appropriate for PRO measurement. PRO development should include literature reviews, patient input, and expert opinion for content domain specification and item generation. Our purpose is to describe initial development of symptom burden PROs for malignant pleural mesothelioma (MPM) and small-cell lung cancer (SCLC).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Thoracic Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect